Effects of subacute treatment with benzopyranopyrimidines in hemostasis and experimental thrombosis in mice

Life Sciences

Volumn 74, Issue 15, 2004, Pages 1851-1859

  Ballabeni, Vigilio ^a   Calcina, Francesco ^a   Tognolini, Massimiliano ^a   Bruno, Olga ^b   Manotti, Cesare ^c   Barocelli, Elisabetta ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Antiplatelets; Antithrombotics; Benzopyranopyrimidine derivatives; Bleeding time; Experimental thrombosis

Indexed keywords

ADRENALIN; ANTITHROMBOCYTIC AGENT; BENZOPYRAN DERIVATIVE; COLLAGEN; FIBRIN; LYSINE ACETYLSALICYLATE; MORPHOLINE DERIVATIVE; PYRIMIDINE DERIVATIVE; THROMBIN;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLEEDING TIME; BLOOD CLOTTING TIME; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; HEMOSTASIS; LUNG EMBOLISM; MALE; MOUSE; NONHUMAN; PARALYSIS; PEPTIC ULCER; RAT; RAT STRAIN; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 0842303043     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.07.052     Document Type: Article

References (21)

1. Antiplatelet Trialist Collaboration British Medical Journal. 308:1994;91-106.
2. Born G.V., Collins R. Aspirin versus clopidogrel: the wrong question? Lancet. 349:1997;806-807.
3. Bruno O., Brullo C., Ranise A., Schenone S., Bondavalli F., Barocelli E., Ballabeni V., Chiavarini M., Tognolini M., Impicciatore M. Synthesis and pharmacological evaluation of 2,5-cycloamino-5H-[1]benzopyrano-[4,3-di] pyrimidines endowed with in vitro antiplatelet activity. Bioorganic and Medicinal Chemistry Letters. 11:2001;1397-1400.
4. Davies M.J., Thomas A.C. Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina. British Heart Journal. 53:1985;363-373.
5. Dejana E., Callioni A., Quintana A., De Gaetano G. Bleeding time in laboratory animals. II-A comparison of different assay conditions in rats. Thrombosis Research. 15:1979;191-197.
6. Dembinska-Kiec A., Pallapies D., Simmet T., Peskar B.M., Peskar B.A. Effect of Carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection. British Journal of Pharmacology. 104(4):1991;811-816.
7. DiMinno G., Silver M.J. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. Journal of Pharmacology and Experimental Therapeutics. 225:1983;57-60.
8. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. New England Journal of Medicine. 326:1992;242-250.
9. Gresele P., Momi S., Berrettini M., Nenci G.G., Schwarz H.P., Semeraro N., Colucci M. Activated human protein C prevents thrombin-induced thromboembolism in mice. Journal of Clinical Investigation. 101(3):1998;667-676.
10. Gresele P., Agnelli G. Novel approaches to the treatment of thrombosis. Trends in Pharmacological Sciences. 23:2002;25-32.
11. Kawano S., Tsuji S. Role of mucosal blood flow: a conceptual review in gastric mucosal injury and protection. Journal of Gastroenterology and Hepatology. 15:2000;D1-D6.
12. Herman A.G. Rationale for the combination of anti-aggregating drugs. Thrombosis Research. 92(11001):1998;S17-S21.
13. Momi S., Emerson M., Paul W., Leone M., Mezzasoma A.M., Del Soldato P., Page C.P., Gresele P. Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin. European Journal of Pharmacology. 397(1):2000;177-185.
14. Momi S., Nasimi M., Colucci M., Nenci G.G., Gresele P. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. Haematologica. 86(6):2001;297-302.
15. Momi S., Nenci G.G., Gresele P. Thrombin-induced thromboembolism in mice: a model for testing antithrombotic agents acting on coagulation/fibrinolysis. Thrombosis Research. 65:1992;S162. (Suppl.).
16. Momo K., Someya K., Tachiiri T., Mitsuoka Y., Nakamura K., Imai S., Ino T., Ohkubo H. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6- tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals. Arzeneimittel-Forschung/Drug Research. 42(1):1992;32-39.
17. Oates P.J., Hakkinen J.P. Studies on the mechanism of ethanol-induced gastric damage in rats. Gastroenterology. 94(1):1988;10-21.
18. Ohno T., Majima M., Hamura M., Katori M., Seaki T., Boku K., Saygenji K. Involvement of platelet aggregation in ethanol-induced rat gastric mucosal injury. Gastroenterology. 112:1997;A242. (Suppl.).
19. Patrono C. Aspirin: new cardiovascular uses for an old drug. American Journal of Medicine. 110(1A):2001;62S-65S.
20. Paul W., Gresele P., Momi S., Bianchi G., Page C.P. The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits. British Journal of Pharmacology. 110(4):1993;1565-1571.
21. Piotrowski J.J., Kumashiro R., Pushkarewicz M.J., Kholoussy A.M., Kuwano H., Matsumoto T. The preventative effect of pyridine on stress ulcers: a microvascular and morphological study. International Surgery. 70(2):1985;109-113.